Cardiovascular Radiology: Page 252

Boston Scientific raises Guidant offer
By AuntMinnie.com staff writers
Boston Scientific has amended its offer to acquire interventional device firm Guidant of Indianapolis to $80 per share of Guidant common stock.
January 16, 2006
Guidant, J&J announce new purchase deal
By AuntMinnie.com staff writers
The stakes are rising in the bidding war for interventional device firm Guidant. Guidant and suitor Johnson & Johnson announced a new purchase deal on Friday that would see J&J pay $24.2 billion for Guidant.
January 15, 2006
Step-and-shoot acquisition cuts CTA dose, improves images
By Eric Barnes
Low-pitch helical acquisition is effective for ensuring complete volume coverage and good phase registration over multiple cardiac cycles. But it packs a high radiation dose and lacks flexibility for irregular heart motion. Researchers have found a potential solution with a "step-and-shoot" acquisition mode for 64-slice CT scanners that can reduce even a modulated dose by 50% or more.
January 15, 2006
2006 01 10 17 19 17 706
Boston Scientific ups Guidant bid
By AuntMinnie.com staff writers
Interventional device firm Boston Scientific has sweetened its bid for Guidant in a move to make its acquisition proposal more competitive with a rival bid from Johnson & Johnson.
January 12, 2006
GE notches all-digital Pepin install
By AuntMinnie.com staff writers
GE Healthcare has installed its clinical and IT systems at Pepin Heart Hospital and Research Institute on the campus of University Community Hospital in Tampa, FL.
January 12, 2006
Guidant, J&J announce new acquisition deal
By AuntMinnie.com staff writers
Interventional device developer Guidant and Johnson & Johnson reported that the firms have reached a new agreement whereby J&J will acquire Indianapolis-based Guidant for $23.2 billion in fully diluted equity value.
January 11, 2006
AuntMinnie.com Cardiac Imaging Radiology Insider
By Eric Barnes
January 10, 2006
Guidant expects Q4 sales downturn
By AuntMinnie.com staff writers
Interventional device firm Guidant said that it believes preliminary unaudited fiscal 2005 fourth-quarter sales will be approximately $828 million, reflecting a decline of approximately 15% compared with the fiscal 2004 fourth quarter.
January 9, 2006
MDCT still can't differentiate between noncalcified plaques
By Eric Barnes
Thin-section multidetector-row CT does a fine job of visualizing calcified atherosclerotic plaque, but is all but blind when it comes to differentiating two important but morphologically distinct types of noncalcified coronary plaque.
January 9, 2006
Tobin extends term with Boston Scientific
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific said that its president and chief executive officer Jim Tobin has agreed to a request from its board of directors to extend his tenure at the firm.
January 4, 2006
Heart rate determines best CTA reconstruction interval
By Eric Barnes
Researchers from Johann Wolfgang Goethe-University in Frankfurt, Germany, have confirmed that heart rate dictates the optimal reconstruction technique in CT angiography.
January 1, 2006
Guidant schedules J&J vote
By AuntMinnie.com staff writers
Shareholders of interventional device firm Guidant of Indianapolis have set January 31 as the date for a vote on the firm's proposed acquisition by Johnson & Johnson of New Brunswick, NJ.
December 29, 2005
Previous Page
Page 252 of 328
Next Page